Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Sep 14

PMID 39272941

Authors

Karam Khaddour

Naoka Murakami

Emily S Ruiz

Ann W Silk

Affiliations

Soon will be listed here.

Abstract

The management of advanced cutaneous squamous cell carcinoma (CSCC) has been revolutionized by the introduction of immunotherapy. Yet, successful treatment with immunotherapy relies on an adequate antitumor immune response. Patients who are solid-organ transplant recipients (SOTRs) have a higher incidence of CSCC compared to the general population. This review discusses the current knowledge of epidemiology, pathophysiology, and management of patients with CSCC who are immunocompromised because of their chronic exposure to immunosuppressive medications to prevent allograft rejection. First, we discuss the prognostic impact of immunosuppression in patients with CSCC. Next, we review the risk of CSCC development in immunosuppressed patients due to SOT. In addition, we provide an overview of the biological immune disruption present in transplanted immunosuppressed CSCC patients. We discuss the available evidence on the use of immunotherapy and provide a framework for the management approach with SOTRs with CSCC. Finally, we discuss potential novel approaches that are being investigated for the management of immunosuppressed patients with CSCC.

References

Reuschenbach M, Tran T, Faulstich F, Hartschuh W, Vinokurova S, Kloor M . High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients. Br J Cancer. 2011; 104(8):1334-41. PMC: 3078602. DOI: 10.1038/bjc.2011.95. View

Hartevelt M, Bavinck J, Kootte A, Vermeer B, Vandenbroucke J . Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990; 49(3):506-9. DOI: 10.1097/00007890-199003000-00006. View

Jew O, Liu W, Stamey C, Kheterpal M, Myers S, Ellis M . De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy. J Am Acad Dermatol. 2024; 91(4):720-722. PMC: 11416314. DOI: 10.1016/j.jaad.2024.05.068. View

Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I . Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results. J Clin Oncol. 2018; 36(25):2612-2620. DOI: 10.1200/JCO.2017.76.6691. View

dIzarny-Gargas T, Durrbach A, Zaidan M . Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review. Am J Transplant. 2020; 20(9):2457-2465. DOI: 10.1111/ajt.15811. View

Lai M, Pampena R, Cornacchia L, Odorici G, Piccerillo A, Pellacani G . Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature. Int J Dermatol. 2021; 61(5):548-557. PMC: 9290486. DOI: 10.1111/ijd.15813. View

Gonzalez J, Cunningham K, Silverman R, Madan E, Nguyen B . Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients. Dermatol Surg. 2017; 43(6):784-791. DOI: 10.1097/DSS.0000000000001038. View

Koch Hein E, Vilbert M, Hirsch I, Ribeiro M, Muniz T, Fournier C . Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers (Basel). 2023; 15(17). PMC: 10487051. DOI: 10.3390/cancers15174312. View

Kosmidis M, Dziunycz P, Suarez-Farinas M, Muhleisen B, Scharer L, Lauchli S . Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. J Immunother. 2010; 33(5):538-46. DOI: 10.1097/CJI.0b013e3181cc2615. View

10.

Ume A, Wenegieme T, Williams C . Calcineurin inhibitors: a double-edged sword. Am J Physiol Renal Physiol. 2020; 320(3):F336-F341. PMC: 7988810. DOI: 10.1152/ajprenal.00262.2020. View

11.

Zaorsky N, Lee C, Zhang E, Keith S, Galloway T . Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis. Radiother Oncol. 2017; 125(1):13-20. PMC: 7534946. DOI: 10.1016/j.radonc.2017.08.011. View

12.

de Oliveira C, Gasparoto T, Pinheiro C, Amor N, Nogueira M, Kaneno R . CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development. Mol Cancer Ther. 2017; 16(12):2871-2880. DOI: 10.1158/1535-7163.MCT-17-0341. View

13.

Polesie S, Gillstedt M, Schmidt S, Egeberg A, Pottegard A, Kristensen K . Use of methotrexate and risk of skin cancer: a nationwide case-control study. Br J Cancer. 2023; 128(7):1311-1319. PMC: 10050200. DOI: 10.1038/s41416-023-02172-7. View

14.

Lindelof B, Sigurgeirsson B, Gabel H, Stern R . Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000; 143(3):513-9. View

15.

Gunaratne D, Veness M . Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: Results of a systematic review. J Med Imaging Radiat Oncol. 2018; 62(3):401-411. DOI: 10.1111/1754-9485.12718. View

16.

Khou S, Popa A, Luci C, Bihl F, Meghraoui-Kheddar A, Bourdely P . Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development. Cancers (Basel). 2020; 12(7). PMC: 7408986. DOI: 10.3390/cancers12071860. View

17.

Rogers H, Weinstock M, Feldman S, Coldiron B . Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015; 151(10):1081-6. DOI: 10.1001/jamadermatol.2015.1187. View

18.

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I . Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012; 367(4):329-39. DOI: 10.1056/NEJMoa1204166. View

19.

Papa M, Vetto J, Ettinghausen S, Mule J, Rosenberg S . Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice. Cancer Res. 1986; 46(11):5618-23. View

20.

Ong C, Keogh A, Kossard S, Macdonald P, Spratt P . Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol. 1999; 40(1):27-34. DOI: 10.1016/s0190-9622(99)70525-6. View